We will also talk about the long-term risks associated with poor design of clinical trials and underline some of the typical reasons why a study fails. Finally, Rupert will give his view on what it takes to design a good trial and how this can best be achieved. So, go in and listen!
Episode #21: Optimise design to minimise elements of failure
In today’s episode of Hedvigpodden you will meet Rupert Dixon, drug development leader at strategic development at IQVIA. Again, this episode will highlight the importance of having a clear goal from the very beginning but this time from a clinical trial perspective.
